[Platelet-rich plasma (PRP) for the treatment of androgenetic alopecia (AGA): a review of the current literature].

4区 医学 Q3 Medicine
Hautarzt Pub Date : 2022-05-01 Epub Date: 2022-04-01 DOI:10.1007/s00105-022-04979-6
P Gressenberger, D Kopera
{"title":"[Platelet-rich plasma (PRP) for the treatment of androgenetic alopecia (AGA): a review of the current literature].","authors":"P Gressenberger, D Kopera","doi":"10.1007/s00105-022-04979-6","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Platelet rich plasma (PRP) injections have been reported to be an effective and low side effect treatment for androgenetic alopecia (AGA). However, robust data concerning this therapy are lacking.</p><p><strong>Aim: </strong>We address some potentially critical aspects of PRP treatment and give some reasons why study results may differ.</p><p><strong>Materials and methods: </strong>In the following review we give a brief overview of the current literature and compare the results of the various trials.</p><p><strong>Results: </strong>In recent years, several clinical trials have been published that have revealed different but rather positive results, which offers hope to those affected by AGA and to physicians as well. However, the results were observed in methodologically weak trials and data from randomized controlled trials are lacking. Differences in trial designs have made it difficult to draw concrete conclusions about its clinical efficacy. Even in the studies where no hair-growth-promoting effect could be observed, the majority of subjects were at least satisfied with the result. The combination of several treatment approaches seems to lead to optimal improvement in hair growth.</p><p><strong>Conclusion: </strong>There are many factors that could have influenced the results of the different studies. The results were observed in methodologically weak studies, giving reason for caution when drawing conclusions. Nevertheless, the majority of the subjects were at least satisfied with the result. Given the current low level of evidence, PRP treatments need to be further investigated in larger studies.</p>","PeriodicalId":12970,"journal":{"name":"Hautarzt","volume":"73 1","pages":"353-357"},"PeriodicalIF":0.0000,"publicationDate":"2022-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Hautarzt","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1007/s00105-022-04979-6","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2022/4/1 0:00:00","PubModel":"Epub","JCR":"Q3","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 0

Abstract

Background: Platelet rich plasma (PRP) injections have been reported to be an effective and low side effect treatment for androgenetic alopecia (AGA). However, robust data concerning this therapy are lacking.

Aim: We address some potentially critical aspects of PRP treatment and give some reasons why study results may differ.

Materials and methods: In the following review we give a brief overview of the current literature and compare the results of the various trials.

Results: In recent years, several clinical trials have been published that have revealed different but rather positive results, which offers hope to those affected by AGA and to physicians as well. However, the results were observed in methodologically weak trials and data from randomized controlled trials are lacking. Differences in trial designs have made it difficult to draw concrete conclusions about its clinical efficacy. Even in the studies where no hair-growth-promoting effect could be observed, the majority of subjects were at least satisfied with the result. The combination of several treatment approaches seems to lead to optimal improvement in hair growth.

Conclusion: There are many factors that could have influenced the results of the different studies. The results were observed in methodologically weak studies, giving reason for caution when drawing conclusions. Nevertheless, the majority of the subjects were at least satisfied with the result. Given the current low level of evidence, PRP treatments need to be further investigated in larger studies.

富血小板血浆(PRP)治疗雄激素性脱发(AGA):当前文献综述。
背景:富血小板血浆(PRP)注射已被报道为雄激素性脱发(AGA)的有效且低副作用的治疗方法。然而,缺乏关于这种疗法的可靠数据。目的:我们讨论了PRP治疗的一些潜在的关键方面,并给出了研究结果可能不同的一些原因。材料和方法:在以下回顾中,我们简要概述了目前的文献,并比较了各种试验的结果。结果:近年来,一些临床试验已经发表,揭示了不同但相当积极的结果,这给AGA患者和医生带来了希望。然而,这些结果是在方法学薄弱的试验中观察到的,并且缺乏随机对照试验的数据。试验设计的差异使得很难得出关于其临床疗效的具体结论。即使在没有观察到促进头发生长效果的研究中,大多数受试者至少对结果感到满意。几种治疗方法的结合似乎导致头发生长的最佳改善。结论:有许多因素可能影响不同研究的结果。这些结果是在方法学薄弱的研究中观察到的,因此在得出结论时要谨慎。然而,大多数受试者至少对结果感到满意。鉴于目前证据水平低,PRP治疗需要在更大规模的研究中进一步调查。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Hautarzt
Hautarzt 医学-皮肤病学
CiteScore
1.40
自引率
0.00%
发文量
93
审稿时长
4-8 weeks
期刊介绍: Der Hautarzt is an internationally recognized journal informing all dermatologists working in practical or clinical environments about important developments in the field of dermatology including allergology, venereology and related areas. Comprehensive reviews on a specific topical issue focus on providing evidenced based information on diagnostics and therapy. Freely submitted original papers allow the presentation of important clinical studies and serve the scientific exchange. Case reports feature interesting cases and aim at optimizing diagnostic and therapeutic strategies. Review articles under the rubric "Continuing Medical Education" present verified results of scientific research and their integration into daily practice.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书